Dr. Kamradt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
85 Retreat Ave
Hartford, CT 06106Phone+1 860-972-4183
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 1996 - 1999
Greenwich Hospital/Yale UniversityResidency, Internal Medicine, 1993 - 1996
Indiana University School of MedicineClass of 1993
Certifications & Licensure
CT State Medical License 1999 - 2025
MI State Medical License 1997 - 2001- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 29 citationsMulticenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner
Journal of Clinical Oncology. 2023-03-10 - 30 citationsNeoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.Samuel A Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan
Journal of Clinical Oncology. 2022-04-20 - 104 citationsOptimum Imaging Strategies for Advanced Prostate Cancer: ASCO GuidelineEdouard J. Trabulsi, R. Bryan Rumble, Hossein Jadvar, Thomas A. Hope, Martin G. Pomper
Journal of Clinical Oncology. 2020-01-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
